Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Express Scripts
McKesson
Moodys
Colorcon

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Cannabinol

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Cannabinol: Sponsors, patents, clinical trial progress

Cannabinol is an investigational drug.

There have been 37 clinical trials for Cannabinol. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2009.

The most common disease conditions in clinical trials are Marijuana Abuse, Chronic Pain, and Vomiting. The leading clinical trial sponsors are Radboud University, Yale University, and National Institute on Drug Abuse (NIDA).

Recent Clinical Trials for Cannabinol
TitleSponsorPhase
Cannabis For Cancer-Related SymptomsPippa HawleyPhase 2
Evaluation of the Pharmacokinetics of Prana P1 CapsulesThe University of The West IndiesPhase 1
Effects of THC and Alcohol on Driving PerformanceOntario Ministry of TransportationPhase 4

See all Cannabinol clinical trials

Clinical Trial Summary for Cannabinol

Top disease conditions for Cannabinol
Top clinical trial sponsors for Cannabinol

See all Cannabinol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Dow
McKesson
Express Scripts
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.